oth lines of evidence suggest that patients with CC may begin with NASH and over the next decade, some progress to cirrhosis.Other features related to metabolic syndrome, such as dyslipidemia, insulin resistance, higher BMI and lower high-density lipoprotein, are more prevalent in CC patients than in control patients with hepatitis B- and C-related cirrhosis, and with primary biliary cirrhosis (PB